Scibase AB

ST:SCIB Sweden Medical Devices
Market Cap
$11.45 Million
Skr128.40 Million SEK
Market Cap Rank
#29307 Global
#421 in Sweden
Share Price
Skr0.31
Change (1 day)
+2.31%
52-Week Range
Skr0.21 - Skr0.45
All Time High
Skr33.21
Categories
Companies in Sweden Medical Devices
About

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin c… Read more

Scibase AB (SCIB) - Net Assets

Latest net assets as of September 2025: Skr33.48 Million SEK

Based on the latest financial reports, Scibase AB (SCIB) has net assets worth Skr33.48 Million SEK as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr53.98 Million) and total liabilities (Skr20.50 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr33.48 Million
% of Total Assets 62.02%
Annual Growth Rate N/A
5-Year Change -21.79%
10-Year Change -87.42%
Growth Volatility 234.46

Scibase AB - Net Assets Trend (2012–2024)

This chart illustrates how Scibase AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Scibase AB (2012–2024)

The table below shows the annual net assets of Scibase AB from 2012 to 2024.

Year Net Assets Change
2024-12-31 Skr36.65 Million -14.88%
2023-12-31 Skr43.06 Million +70.61%
2022-12-31 Skr25.24 Million -64.35%
2021-12-31 Skr70.80 Million +51.08%
2020-12-31 Skr46.86 Million +46.38%
2019-12-31 Skr32.01 Million -55.21%
2018-12-31 Skr71.48 Million -38.23%
2017-12-31 Skr115.72 Million -37.58%
2016-12-31 Skr185.41 Million -36.38%
2015-12-31 Skr291.42 Million +792.69%
2014-12-31 Skr32.65 Million -9.77%
2013-12-31 Skr36.18 Million +252.73%
2012-12-31 Skr-23.69 Million --

Equity Component Analysis

This analysis shows how different components contribute to Scibase AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 71042925900.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock Skr10.98 Million 29.95%
Other Comprehensive Income Skr720.00K 1.96%
Other Components Skr759.38 Million 2071.98%
Total Equity Skr36.65 Million 100.00%

Scibase AB Competitors by Market Cap

The table below lists competitors of Scibase AB ranked by their market capitalization.

Company Market Cap
Alianza Minerals Ltd
OTCQB:TARSF
 		$8.38 Million
General Environmental Management Inc
PINK:GEVI
 		$8.38 Million
Solueta Co Ltd
KQ:154040
 		$8.38 Million
Infrared Cameras Holdings Inc
NASDAQ:MSAI
 		$8.38 Million
Phol Dhanya Public Company Limited
BK:PHOL
 		$8.38 Million
Careplus Group Bhd
KLSE:0163
 		$8.38 Million
Cielo Waste Solutions Corp
PINK:CWSFF
 		$8.38 Million
Organic Tea Cosmetics Holdings Company Limited
KQ:900300
 		$8.37 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Scibase AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 43,056,000 to 36,650,000, a change of -6,406,000 (-14.9%).
  • Net loss of 61,125,000 reduced equity.
  • Share repurchases of 41,877,000 reduced equity.
  • New share issuances of 41,877,000 increased equity.
  • Other comprehensive income increased equity by 343,000.
  • Other factors increased equity by 54,376,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income Skr-61.12 Million -166.78%
Share Repurchases Skr41.88 Million -114.26%
Share Issuances Skr41.88 Million +114.26%
Other Comprehensive Income Skr343.00K +0.94%
Other Changes Skr54.38 Million +148.37%
Total Change Skr- -14.88%

Book Value vs Market Value Analysis

This analysis compares Scibase AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.51x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2012-12-31 Skr-0.34 Skr0.31 x
2013-12-31 Skr4.28 Skr0.31 x
2014-12-31 Skr3.86 Skr0.31 x
2015-12-31 Skr24.88 Skr0.31 x
2016-12-31 Skr12.75 Skr0.31 x
2017-12-31 Skr7.77 Skr0.31 x
2018-12-31 Skr2.51 Skr0.31 x
2019-12-31 Skr1.15 Skr0.31 x
2020-12-31 Skr1.45 Skr0.31 x
2021-12-31 Skr1.10 Skr0.31 x
2022-12-31 Skr0.36 Skr0.31 x
2023-12-31 Skr0.40 Skr0.31 x
2024-12-31 Skr0.21 Skr0.31 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Scibase AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -166.78%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -205.77%
  • • Asset Turnover: 0.48x
  • • Equity Multiplier: 1.68x
  • Recent ROE (-166.78%) is below the historical average (-91.61%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2012 0.00% 0.00% 0.00x 0.00x Skr-38.60 Million
2013 -219.75% -81960.82% 0.00x 1.21x Skr-83.12 Million
2014 -118.72% -2422.19% 0.04x 1.27x Skr-42.02 Million
2015 -14.25% -1000.53% 0.03x 0.53x Skr-70.67 Million
2016 -28.63% -824.83% 0.06x 0.55x Skr-71.63 Million
2017 -36.69% -619.10% 0.05x 1.11x Skr-54.04 Million
2018 -61.86% -640.89% 0.09x 1.13x Skr-51.36 Million
2019 -123.51% -426.25% 0.20x 1.44x Skr-42.74 Million
2020 -74.67% -367.49% 0.16x 1.26x Skr-39.67 Million
2021 -58.89% -355.50% 0.14x 1.21x Skr-48.77 Million
2022 -158.10% -223.02% 0.36x 1.98x Skr-42.42 Million
2023 -129.10% -239.13% 0.36x 1.49x Skr-59.89 Million
2024 -166.78% -205.77% 0.48x 1.68x Skr-64.79 Million

Industry Comparison

This section compares Scibase AB's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $75,200,026
  • Average return on equity (ROE) among peers: -74.39%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Scibase AB (SCIB) Skr33.48 Million 0.00% 0.61x $8.38 Million
Acarix A/S (ACARIX) $76.60 Million -60.65% 0.08x $28.86 Million
Arcoma AB (ARCOMA) $12.52 Million -92.85% 4.66x $8.93 Million
Bactiguard Holding AB (publ) (BACTI-B) $353.18 Million -39.18% 0.87x $19.20 Million
CellaVision AB (CEVI) $20.07 Million 13.08% 1.20x $262.59 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $65.69 Million -72.50% 0.20x $13.78 Million
Chordate Medical Holding AB (CMH) $38.95 Million -55.88% 0.13x $17.64K
Coala Life Group AB (COALA) $52.33 Million -287.99% 0.53x $468.93K
C-Rad AB (publ) (CRAD-B) $93.64 Million 22.63% 0.57x $56.67 Million
Duearity AB (DEAR) $-2.39 Million 0.00% 0.00x $34.43K
Episurf Medical AB (publ) (EPIS-B) $41.40 Million -170.53% 0.39x $5.40 Million